| Literature DB >> 11489510 |
I P Gladysheva1, O V Polekhina, T A Karmakova, E R Nemtsova, R I Yakubovskaya, W C Shen, A R Kennedy, N I Larionova.
Abstract
The present work reports the effect of conjugation of the anticarcinogenic and antitumor soybean Bowman-Birk protease inhibitor (BBI) with amphiphilic block copolymer of ethylene oxide and propylene oxide (PEO-PPO) as well as with monoclonal antibody via clinical dextran (D) on tumor-targeted delivery of BBI.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11489510 DOI： 10.1016/s0168-3659(01)00337-6
Source DB: PubMed Journal: J Control Release ISSN： 0168-3659 Impact factor: 9.776